<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Meng Qi (Maxi) -->
          <cik>0002148957</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Class A Ordinary Shares, par value $0.008 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>08/03/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001986247</issuerCik>
        <issuerName>Park Ha Biological Technology Co., Ltd.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>G6925R128</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>901 &amp; 902-2, Building C, Phase 2, Wuxi I</com:street1>
          <com:street2>196 Jinghui East Road, Xinwu District, W</com:street2>
          <com:city>Jiangsu Province</com:city>
          <com:stateOrCountry>F4</com:stateOrCountry>
          <com:zipCode>214000</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Peverel Summit Holdings Limited</reportingPersonName>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>422500.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>422500.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>422500.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>(1) Includes 260,000 Class A Ordinary Shares for which Warrants are exercisable within the next 60 days.

(2) Based on (i) 2,297,902 Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026, as set forth in the Issuer's Form 6-K filed with the Securities and Exchange Commission ("SEC") on August 3, 2026 plus (ii) 2,000,000 Class A Ordinary Shares underlying a warrant which is exercisable within the next 60 days.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Qi Meng</reportingPersonName>
      <citizenshipOrOrganization>F4</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>422500.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>422500.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>422500.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.8</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) Includes 260,000 Class A Ordinary Shares for which Warrants are exercisable within the next 60 days.

(2) Based on (i) 2,297,902 Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026, as set forth in the Issuer's Form 6-K filed with the SEC on August 3, 2026 plus (ii) 2,000,000 Class A Ordinary Shares underlying a warrant which is exercisable within the next 60 days.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Park Ha Biological Technology Co., Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>901 &amp; 902-2, Building C, Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, Ch</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Peverel Summit Holdings Limited, and Qi Meng (each, a "Reporting Person" and collectively, the "Reporting Persons")</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address of the principal business office of each of the reporting persons is No. 23, Zhuzhuang Group, Sunxu Neighborhood Committee, Zhuma Street, Lianshui County, Jiangsu Province,China.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>See Item 4 on the cover page hereto.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Peverel Summit Holdings Limited: 425,500; and Qi Meng: 422,500. Ownership percentages are based on (i) 2,297,902 Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026, as set forth in the Issuer's Form 6-K filed with the SEC on August 3, 2026 plus (ii) 2,000,000 Class A Ordinary Shares underlying a warrant which is exercisable within the next 60 days.</amountBeneficiallyOwned>
        <classPercent>See response to Item 11 on the cover page.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See response to Item 5 on the cover page.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See response to Item 6 on the cover page.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See response to Item 7 on the cover page.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See response to Item 8 on the cover page.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Peverel Summit Holdings Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Qi Meng</signature>
        <title>Qi Meng, Director</title>
        <date>08/10/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Qi Meng</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Qi Meng</signature>
        <title>Qi Meng</title>
        <date>08/10/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
